Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2020 5
2021 12
2022 12
2023 8
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean peanut (20,393 results)?
Association of patent ductus arteriosus treatment in extremely low gestational age neonates with two year kidney outcomes: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT).
Condit PE, Guillet R, Kaluarachchi D, Griffin RL, Menon S, Askenazi DJ, Harer MW. Condit PE, et al. BMC Nephrol. 2025 Mar 19;26(1):138. doi: 10.1186/s12882-025-04065-8. BMC Nephrol. 2025. PMID: 40108500 Free PMC article. Clinical Trial.

METHODS: Secondary analysis of prospectively collected data from the PENUT trial. Kidney dysfunction defined by: eGFR < 90 mL/min/1.73 m(2), systolic or diastolic blood pressures (SBP or DBP) > 90th percentile, or proteinuria measured by albumin to creatinine ratio (

…

METHODS: Secondary analysis of prospectively collected data from the PENUT trial. Kidney dysfunction defined by: eGFR < 90 mL/min/

…
Association of delayed cord clamping with acute kidney injury and two-year kidney outcomes in extremely premature neonates: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT).
Zapata HA, Todurkar N, Favel K, Griffin RL, Starr MC, Charlton JR, McAdams RM, Askenazi D, Kulkarni T, Menon S, Mammen C, Harer MW. Zapata HA, et al. J Perinatol. 2025 Jan;45(1):85-93. doi: 10.1038/s41372-024-02143-7. Epub 2024 Oct 11. J Perinatol. 2025. PMID: 39390245 Clinical Trial.
Association of delayed cord clamping with acute kidney injury and two-year kidney outcomes in extremely premature neonates: a secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT).
Harer M, Zapata H, Todurkar N, Favel K, Griffin R, Starr M, Charlton J, McAdams R, Askenazi D, Kulkarni T, Menon S, Mammen C. Harer M, et al. Res Sq [Preprint]. 2024 Jul 19:rs.3.rs-4631779. doi: 10.21203/rs.3.rs-4631779/v1. Res Sq. 2024. Update in: J Perinatol. 2025 Jan;45(1):85-93. doi: 10.1038/s41372-024-02143-7. PMID: 39070632 Free PMC article. Updated. Preprint.
Time to regain birthweight and association with neurodevelopmental outcomes among extremely preterm newborns.
Valentine GC, Perez KM, Wood TR, Mayock DE, Law JB, Kolnik S, Strobel KM, Brandon OC, Comstock BA, Heagerty PJ, Juul SE. Valentine GC, et al. J Perinatol. 2024 Apr;44(4):554-560. doi: 10.1038/s41372-024-01869-8. Epub 2024 Jan 9. J Perinatol. 2024. PMID: 38195922 Clinical Trial.
CONCLUSION: Faster nadir-to-regain and excessive cumulative weight loss are associated with adverse 2-year neurodevelopmental outcomes. TRIAL REGISTRATION: PENUT Trial Registration: NCT01378273. https://clinicaltrials.gov/ct2/show/NCT01378273 . CLINICAL TRIAL REGISTRATION: …
CONCLUSION: Faster nadir-to-regain and excessive cumulative weight loss are associated with adverse 2-year neurodevelopmental outcomes. TRIA …
Contemporary definitions of infant growth failure and neurodevelopmental and behavioral outcomes in extremely premature infants at two years of age.
Strobel KM, Wood TR, Valentine GC, German KR, Gogcu S, Hendrixson DT, Kolnik SE, Law JB, Mayock DE, Comstock BA, Heagerty PJ, Juul SE. Strobel KM, et al. J Perinatol. 2024 Jun;44(6):811-818. doi: 10.1038/s41372-023-01852-9. Epub 2024 Jan 9. J Perinatol. 2024. PMID: 38195921 Free PMC article.
CLINICAL TRIAL REGISTRATION: This study is a secondary analysis of pre-existing data from the PENUT Trial Registration: NCT01378273....
CLINICAL TRIAL REGISTRATION: This study is a secondary analysis of pre-existing data from the PENUT Trial Registration: NCT01378273.. …
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates.
Hingorani SR, Schmicker RH, Halloran B, Brophy P, Heagerty PJ, Juul S, Goldstein SL, Askenazi D; PENUT Investigators. Hingorani SR, et al. Am J Kidney Dis. 2024 Apr;83(4):497-507. doi: 10.1053/j.ajkd.2023.09.008. Epub 2023 Nov 4. Am J Kidney Dis. 2024. PMID: 37926336 Free PMC article.
SETTING & PARTICIPANTS: 327 neonates born at 24-27 weeks' gestation with 2-year eGFR data from the PENUT (Preterm Erythropoietin Neuroprotection Trial) and the REPaIReD (Recombinant Erythropoietin for Prevention of Infant Renal Disease) study. ...
SETTING & PARTICIPANTS: 327 neonates born at 24-27 weeks' gestation with 2-year eGFR data from the PENUT (Preterm Erythropoietin …
Time to Regain Birthweight and Association with Neurodevelopmental Outcomes among Extremely Preterm Newborns.
Valentine G, Perez K, Wood T, Mayock D, Law J, Kolnik S, Strobel K, Brandon O, Comstock B, Heagerty P, Juul S. Valentine G, et al. Res Sq [Preprint]. 2023 Sep 14:rs.3.rs-3249598. doi: 10.21203/rs.3.rs-3249598/v1. Res Sq. 2023. Update in: J Perinatol. 2024 Apr;44(4):554-560. doi: 10.1038/s41372-024-01869-8. PMID: 37790304 Free PMC article. Updated. Preprint.
CONCLUSION: Faster nadir-to-regain and prolonged, severe weight loss are associated with adverse 2-year neurodevelopmental outcomes. TRIAL REGISTRATION: PENUT Trial Registration: NCT01378273. https://clinicaltrials.gov/ct2/show/NCT01378273....
CONCLUSION: Faster nadir-to-regain and prolonged, severe weight loss are associated with adverse 2-year neurodevelopmental outcomes. TRIAL R …
Acute Kidney Injury Defined by Fluid-Corrected Creatinine in Premature Neonates: A Secondary Analysis of the PENUT Randomized Clinical Trial.
Starr MC, Griffin RL, Harer MW, Soranno DE, Gist KM, Segar JL, Menon S, Gordon L, Askenazi DJ, Selewski DT. Starr MC, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2328182. doi: 10.1001/jamanetworkopen.2023.28182. JAMA Netw Open. 2023. PMID: 37561461 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: This study was a post hoc cohort analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT), a phase 3, randomized clinical trial of erythropoietin, conducted at 19 academic centers and 30 neonatal intensive care units in the US …
DESIGN, SETTING, AND PARTICIPANTS: This study was a post hoc cohort analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT …
Patterns of Infections among Extremely Preterm Infants.
Perez K, Puia-Dumitrescu M, Comstock BA, Wood TR, Mayock DE, Heagerty PJ, Juul SE, On Behalf Of The Penut Consortium. Perez K, et al. J Clin Med. 2023 Apr 4;12(7):2703. doi: 10.3390/jcm12072703. J Clin Med. 2023. PMID: 37048786 Free PMC article.
To evaluate the incidence, pathogenesis, and in-hospital outcomes associated with sepsis among hospitalized extremely preterm infants born at 24-0/7 to 27-6/7 weeks of gestation, we designed a post hoc analysis of data collected prospectively during the Preterm Epo Neuroprotectio …
To evaluate the incidence, pathogenesis, and in-hospital outcomes associated with sepsis among hospitalized extremely preterm infants born a …
40 results